Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

Latest News

An efficient, safe route to EED Article 8 compliance for all your European sites

Posted on

The 2012 Energy Efficiency Directive establishes a set of binding measures to help the EU reach its 20% energy efficiency target by 2020.

Under Article 8 of this directive, each EU Member State must meet certain energy savings targets between 1 January 2014 and 31 December 2020.

In the UK, the Energy Savings Opportunity Scheme (ESOS) has been established to ensure that businesses which meet the qualifying criteria are doing their bit to contribute to the overall energy efficiency target.

Although ESOS is a UK directive, there are similar requirements for all EU Member States.

As a specialist provider of energy efficiency solutions to the pharmaceutical sector and an accredited ESOS lead assessor, EECO2 can guide you through the EED compliance process from audit to remedial actions.

Phase 2 of Article 8 compliance is now underway. Starting the process now means more time for remedial actions and not having to worry about assessor availability as the deadline approaches (5 December 2019).

We understand that multiple sites across multiple countries can be a regulatory headache, but our expertise in international energy management means that we can manage this process for you smoothly and efficiently.

To find out more about our tailored packages for EED compliance click here – or contact us today for an informal chat about your requirements.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

First up, it is the #CIBSEShortlist for Building Performance Consultancy (up to 50 employees):
EECO2 @EECO2_Energy
FairHeat @FairHeat
grfn @ConsultGRFN
Lawler Consulting formerly known as Noel Lawler Consulting Engineers @Lawler_Consult
#BPA2021

Proud to announce that EECO2 has been shortlisted for the CIBSE Building Performance Awards 2021 #BPA2021 #welldoneteam @CIBSEAwards #fingerscrossed

Pfizer and BioNTech announce trial data showing COVID-19 vaccine is more than 90% effective. https://twitter.com/i/events/1325768958331383809

#pharma #COVID19

Sign up to the knowledge hub

  • By completing this form, you confirm that we may contact you via email, that you are over the age of 16 and that we can send you periodic emails, containing useful and interesting information including our email newsletter. Please see our privacy policy for more information and to see how you can manage your consent.

  • Fields marked with an * are mandatory